News & Events
European Medicines Agency recommends market authorisation for ocrelizumab (Ocrevus) in EU
The EMA has recommended that ocrelizumab (Ocrevus), the first disease-modifying treatment for primary progressive MS (PPMS), be…
Using Data to individualise patient treatments
Scientists have been using a large database to develop algorithms to predict individual responses to a particular…
A new potential biomarker for the diagnosis of MS
A new small study has discovered molecules in the blood that are specific to people with MS,…
Electric stimulation may help manage MS related fatigue
Researchers have been trialling low current electric brain stimulation as a way to help manage MS related…
Anti-histamine trial shows myelin repair possible
Anti-histamine drug clemastine may boost myelin repair in MS
MSIF visits Saudi Arabia to launch new country-focused programme
MSIF’s Capacity Building Manager visits Arfa MS Society to launch MSIF’s new country-focused programme in the Kingdom…
MS Society of India volunteer who lives with MS wins award in national pageant
The MS Society of India (MSSI) is proud to congratulate Dr Rebecca Verghese, a long-standing volunteer with…
Argentinian MS Society launches new website and YouTube channel
Multiple Sclerosis Argentina (EMA) has launched a brand new website and YouTube channel in order to increase…
Polish MS Society marks tenth year of national MS awareness-raising campaign
The Polish MS Society’s annual awareness-raising campaign, “Symphony of Hearts”, has entered its tenth year
Russian MS Society reflects on learnings from MSIF 50th anniversary meetings
At MSIF’s recent 50th anniversary meetings, Igor Tsykorin, president of the Russian MS Society, became the first…
Inflammation and anxiety: how are they linked?
Chemistry of brain inflammation linked to mood changes in MS
Does concussion increase the risk of MS?
What’s behind the media reports on concussion and MS?